Evidence map›Paper›PMID 22662174›Full record

ArticlePloS one2012

MRI tracking of FePro labeled fresh and cryopreserved long term in vitro expanded human cord blood AC133+ endothelial progenitor cells in rat glioma.

Branislava Janic, Kourosh Jafari-Khouzani, Abbas Babajani-Feremi, A S M Iskander, Nadimpalli Ravi S Varma, Meser M Ali, Robert A Knight, Ali S Arbab

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Branislava JanicCellular and Molecular Imaging Laboratory, Department of Radiology, Henry Ford Hospital, Detroit, Michigan, United States of America. bjanic@rad.hfh.edu
Kourosh Jafari-Khouzani
Abbas Babajani-Feremi
A S M Iskander
Nadimpalli Ravi S Varma
Meser M Ali
Robert A Knight
Ali S Arbab
Henry Ford Health System · USHenry Ford Hospital · US

Funding

TH and GTPCHI gene therapy for Parkinson's diseaseR01NS055143 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI KORDOWER, JEFFREY H · 2007 to 2010
$2.1M
Cellular MRI in Glioma and Radiation NecrosisR01CA122031 · NCI · HENRY FORD HEALTH SYSTEM · PI ARBAB, ALI SYED · 2007 to 2010
$992k
Assessments of Multiple Breast Cancer Biomarkers with Dendritic MRI ProbesK25CA129173 · NCI · HENRY FORD HEALTH SYSTEM · PI ALI, MESER M. · 2009 to 2012
$518k
Stem Cells as Delivery Vehicles and Imaging Probes for Glioma Gene TherapyR21CA129801 · NCI · HENRY FORD HEALTH SYSTEM · PI ARBAB, ALI SYED · 2008 to 2009
$359k
MR Imaging of pHe and Chemotherapeutic Response in a Rat GliomaR21NS066143 · NINDS · HENRY FORD HEALTH SYSTEM · PI ALI, MESER M. · 2009 to 2010
$325k
NCI NIH HHS K25 CA129173NCI NIH HHS K25 CA 129173-01A2NCI NIH HHS R01 CA 122031NCI NIH HHS R01 CA122031NCI NIH HHS R21 CA129801NINDS NIH HHS R01 NS055143NINDS NIH HHS R21 NS 055143-01NINDS NIH HHS R21 NS066143
6 · The paper itself

Abstract

backgroundEndothelial progenitors cells (EPCs) are important for the development of cell therapies for various diseases. However, the major obstacles in developing such therapies are low quantities of EPCs that can be generated from the patient and the lack of adequate non-invasive imaging approach for in vivo monitoring of transplanted cells. The objective of this project was to determine the ability of cord blood (CB) AC133+ EPCs to differentiate, in vitro and in vivo, toward mature endothelial cells (ECs) after long term in vitro expansion and cryopreservation and to use magnetic resonance imaging (MRI) to assess the in vivo migratory potential of ex vivo expanded and cryopreserved CB AC133+ EPCs in an orthotopic glioma rat model. MATERIALS, METHODS AND

resultsThe primary CB AC133+ EPC culture contained mainly EPCs and long term in vitro conditions facilitated the maintenance of these cells in a state of commitment toward endothelial lineage. At days 15-20 and 25-30 of the primary culture, the cells were labeled with FePro and cryopreserved for a few weeks. Cryopreserved cells were thawed and in vitro differentiated or i.v. administered to glioma bearing rats. Different groups of rats also received long-term cultured, magnetically labeled fresh EPCs and both groups of animals underwent MRI 7 days after i.v. administration of EPCs. Fluorescent microscopy showed that in vitro differentiation of EPCs was not affected by FePro labeling and cryopreservation. MRI analysis demonstrated that in vivo accumulation of previously cryopreserved transplanted cells resulted in significantly higher R2 and R2* values indicating a higher rate of migration and incorporation into tumor neovascularization of previously cryopreserved CB AC133+ EPCs to glioma sites, compared to non-cryopreserved cells.

conclusionMagnetically labeled CB EPCs can be in vitro expanded and cryopreserved for future use as MRI probes for monitoring the migration and incorporation to the sites of neovascularization.

Indexed as

Cell TrackingMagnetic Resonance ImagingAC133 AntigenAnimalsAntigens, CDCell DifferentiationCell Line, TumorCell MovementCells, CulturedContrast MediaCryopreservationDextransEndothelial CellsEndothelium, VascularFetal BloodGliomaAC133 AntigenAntigens, CDContrast MediaDextransferumoxidesGlycoproteinsMagnetite NanoparticlesPeptidesPROM1 protein, humanProtamines

Identifiers

PMID22662174
PMCPMC3360770
OpenAlexW2000866272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.